Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Morocco reports first case of new coronavirus variant

Mon, 18th Jan 2021 22:42

Rabat, Jan 18 (Reuters) - Morocco’s health ministry
confirmed on Monday its first imported case of the more
contagious variant of the novel coronavirus first discovered in
the UK.

The variant was detected in the northern port of Tangier in
a Moroccan national returning from Ireland via Marseille, the
ministry said in a statement.

Morocco has announced it plans to launch a free vaccination
campaign targeting 25 million people, or 80% of its population.

The country ordered 66 million vaccine doses from
AstraZeneca Plc and China’s Sinopharm. It has not yet
received any.

On Dec. 23, Morocco imposed a nationwide four-week curfew
from 9:00 pm to 6:00 am to contain virus.

On Monday, the country said it has recorded a total of
460,144 coronavirus infections including 7,977 deaths and 16,481
active cases.

Health experts have raised concerns over new highly
transmissible mutations of the virus first reported in the UK
and South Africa and now cropping up in several other countries.
A third new variant has since been reported in Brazil.
(Reporting by Ahmed Eljechtimi
Editing by Bill Berkrot)

Related Shares

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.